Adverum Biotechnologies
ADVM
ADVM
55 hedge funds and large institutions have $45M invested in Adverum Biotechnologies in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
55
Holders Change
-4
Holders Change %
-6.78%
% of All Funds
0.88%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
14
Reduced
18
Closed
9
Calls
$58K
Puts
–
Net Calls
+$58K
Net Calls Change
-$701K
Top Buyers
| 1 |
CC
Commodore Capital
New York
|
$3.59M |
| 2 |
Goldman Sachs
New York
|
$3.27M |
| 3 |
CM
CM Management
Gulf Breeze,
Florida
|
$269K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$2.97M |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
$66.8K |
